New Function for Safety Signal Monitoring in MID‐NET®: The Case of an Anti‐COVID‐19 Drug

New Function for Safety Signal Monitoring in MID‐NET®: The Case of an Anti‐COVID‐19 Drug

ABSTRACT Real‐world data play a key role in monitoring drug safety at the post‐marketing stage. However, challenges on how to rapidly and continuously obtain analytical results of many outcomes for drug safety signal monitoring still remain. We aimed to establish a rapid and continuous monitoring to...

Full description

Saved in:
Bibliographic Details
Main Authors: Yusuke Okada, Takashi Ando, Fumitaka Takahashi, Kenichi Watanabe, Kazuhiro Kajiyama, Tomoaki Hasegawa, Satomi Inomata, Yuki Kinoshita, Shinya Watanabe, Yoshiaki Uyama
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Clinical and Translational Science
Subjects:
medical information database
post‐marketing drug safety
real‐word evidence
safety signal monitoring
Online Access:https://doi.org/10.1111/cts.70208
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1111/cts.70208

Similar Items